Inherited Mutations in 18 Percent With Ovarian Cancer

This article originally appeared here.
Share this content:
Inherited Mutations in 18 Percent With Ovarian Cancer
Inherited Mutations in 18 Percent With Ovarian Cancer

WEDNESDAY, Jan. 6, 2016 (HealthDay News) -- Pathogenic germline mutations are common in women with ovarian, fallopian tube, and peritoneal carcinoma (OC), according to a study published online Dec. 30 in JAMA Oncology.

Barbara M. Norquist, M.D., from the University of Washington in Seattle, and colleagues examined the frequency and importance of germline mutations in cancer-associated genes in OC. Data were included for 1,915 women with OC and available germline DNA identified from the University of Washington (UW) gynecologic tissue bank and from the Gynecologic Oncology Group (GOG) phase III clinical trials 218 and 262.

The researchers found that in patients recruited from UW there was a higher proportion of fallopian tube cancers, stage I and II disease, and nonserous carcinomas; a higher number of black women were recruited from the GOG trials. Fifteen percent of patients had mutations in BRCA1 or BRCA2, and 0.4 percent had mutations in DNA mismatch repair genes. Mutations in BRIP1, RAD51C, RAD51D, PALB2, and BARD1 were present in 3.3 percent of patients with OC, significantly more common than in the National Heart, Lung, and Blood Institute GO Exome Sequencing Project and the Exome Aggregation Consortium. Mutation frequency was not predicted by race, histologic subtype, or disease site. Compared to those without mutations, patients with a BRCA2 mutation from the GOG trials had longer progression-free and overall survival.

"Of 1,915 patients with OC, 347 (18 percent) carried pathogenic germline mutations in genes associated with OC risk," the authors write.

Two authors disclosed financial ties to the biopharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »